Human tissue levels and plasma pharmacokinetics of Temoporfin (Foscan®, mTHPC)

Lasers in Medical Science

Volumn 11, Issue 4, 1996, Pages 267-272

  Ronn, A M ^a,b,c   Nouri, M ^a   Lofgren, L A ^a,b   Steinberg, B M ^a   Westerborn, A ^b   Windahl, T ^b   Shikowitz, M J ^a   Abramson, A L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^c LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

Human; mTHPC; Pharmacokinetics; Photodynamic therapy; Photosensitizer; Temoporfin

Indexed keywords

PHOTOSENSITIZING AGENT; TEMOPORFIN;

ARTICLE; BASAL CELL NEVUS SYNDROME; BRONCHUS CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HALF LIFE; HUMAN; HUMAN TISSUE; LARYNX CANCER; LARYNX PAPILLOMATOSIS; MESOTHELIOMA; NASOPHARYNX CANCER; PHASE 1 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; SPECTROFLUOROMETRY; TISSUE LEVEL;

EID: 0030473879     PISSN: 02688921     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02134918     Document Type: Article

References (16)

1. von Tappiener H, Jesionek A. Therapeutische versiche mit fluoreszierenden Stoffen. Muench Med Wochenschr 1903, 50:2042-4
2. Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle D, Mittleman A Photoradiation therapy for the treatment of malignant tumours. Cancer Res 1978, 38:2628-35
3. Bonnett R. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem Soc Rev 1995, 24:19-33
4. Proceedings, VI Biennial Meeting of the International Photodynamic Association, Melbourne, March 1996
5. Lofgren LA, Ronn AM, Abramson AL et al. Photodynamic therapy using meso-tetra (hydroxyphenyl) chlorin: an animal model. Arch Otol Head Neck Surg 1994, 120:1355-62
6. Lofgren LA, Ronn AM, Abramson AL, Shikowitz MJ, Nouri M, Steinberg BM. A standardized methodology for evaluation of photoactive anti-tumor agents as applied to meta-tetra (hydroxyphenyl) chlorin. In: Horrobin DF (ed) New Approaches to Cancer Treatment. London: Churchill Communications Europe, 1994:133-41
7. Abramson AL, Lofgren LA, Ronn AM, Nouri M, Steinberg BM. Treatment effects of meta-tetra (hydroxyphenyl) chlorin on the larynx. In: Horrobin DF (ed) New Approaches to Cancer Treatment. London: Churchill Communications Europe, 1994:142-7
8. Berenbaum MC. Comparison of hematoporphyrin derivatives and new photosensitize. In: Photosensitizing Compounds: Their Chemistry, Biology and Clinical Use, Ciba Foundation Symposium, Vol. 146. Chichester: John Wiley and Sons Inc., 1989:33-40
9. Bonnett R, White RD, Winfield UJ, Berenbaum MC. Hydroporphyrins of the meso-tetra (hydroxyphenyl) porphyrin series as tumor photosensitizers. Biochem J 1989, 260:277-80
10. Lofgren LA, Ronn AM. Meso-tetra (hydroxyphenyl) chlorin - An in vivo photodegradation study. Proceedings of Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy III 1994, 2133:112-5
11. Ronn AM, Batti J. Lee CJ et al. Comparative biodistribution of m-THPC in multiple species: clinical implications for photodynamic therapy. Lasers Surg Med (in press)
12. Lofgren LA, Ronn AM. Tissue dependent biosynthesis and pharmacokinetics of Protoporphyrin IX following intravenous injection of aminolevulinic acid. Proceedings of Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy IV 1995, 2392:80-92
13. Peng Q, Moan J, Ma L-W, Nesland JM, Uptake, localization, and photodynamic effect of meso-Tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma. Cancer Res 1995, 55:2620-6
14. Fisher AMR, Murphree AL, Gomer CJ. Clinical and preclinical photodynamic therapy. Lasers Surg Med 1995, 17:2-31
15. Korbelik M, Krosl G. Cellular levels of photosensitizers in tumors: the role of proximity to the blood supply. Breast Cancer 1994, 70:604-10
16. Ma L, Moan J, Berg K. Evaluation of a new photosensitizer, meso-tetra-hydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers. Int J Cancer 1994, 57:883-888